Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action
Vittorio Pavoni, Lara Gianesello, Maddalena Pazzi, Caterina Stera, Tommaso Meconi, Francesca Covani Frigieri
Topics & Concepts
MedicineCritically illHeparinVenous thromboembolismAspirinCoronavirus disease 2019 (COVID-19)Low molecular weight heparinIntensive care medicineThrombosisInternal medicineDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesVenous Thromboembolism Diagnosis and ManagementHeparin-Induced Thrombocytopenia and Thrombosis